We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+8.26%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$16.5M
Cap. Flow
+$4.95M
Cap. Flow %
2.71%
Top 10 Hldgs %
70.41%
Holding
624
New
37
Increased
151
Reduced
119
Closed
30

Top Buys

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$3.19M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$908K
3
NVDA icon
NVIDIA
NVDA
+$764K
4
EVH icon
Evolent Health
EVH
+$528K
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$399K

Top Sells

Rank Stock Value
1
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$431K
2
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$417K
3
IWM icon
iShares Russell 2000 ETF
IWM
+$337K
4
PRLB icon
Protolabs
PRLB
+$293K
5
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$176K

Sector Composition

Rank Sector Weight
1 Healthcare 13.01%
2 Financials 4.64%
3 Technology 4.06%
4 Industrials 1.41%
5 Consumer Discretionary 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCX icon
551
BlackRock Resources & Commodities Strategy Trust
BCX
$896M
$439 ﹤0.01%
46
+1
+2% +$9
OSUR icon
552
OraSure Technologies
OSUR
$273M
$427 ﹤0.01%
100
– –
ACHR icon
553
Archer Aviation
ACHR
$3.42B
$394 ﹤0.01%
130
– –
C icon
554
Citigroup
C
$213B
$374 ﹤0.01%
6
– –
UAA icon
555
Under Armour
UAA
$3.01B
$374 ﹤0.01%
42
– –
TSVT
556
DELISTED
2seventy bio
TSVT
$359 ﹤0.01%
76
– –
SLVM icon
557
Sylvamo
SLVM
$1.52B
$351 ﹤0.01%
4
– –
UA icon
558
Under Armour Class C
UA
$2.95B
$351 ﹤0.01%
42
– –
RH icon
559
RH
RH
$3.33B
$334 ﹤0.01%
1
-3
-75% -$826
PEB icon
560
Pebblebrook Hotel Trust
PEB
$2.18B
$320 ﹤0.01%
24
– –
CHPT icon
561
ChargePoint
CHPT
$134M
$307 ﹤0.01%
11
– –
ADAP
562
DELISTED
Adaptimmune Therapeutics
ADAP
$273 ﹤0.01%
287
– –
OUST icon
563
Ouster
OUST
$2.11B
$258 ﹤0.01%
41
– –
CUTR
564
DELISTED
Cutera, Inc.
CUTR
$249 ﹤0.01%
316
– –
BHF icon
565
Brighthouse Financial
BHF
$3.61B
$225 ﹤0.01%
5
– –
VMBS icon
566
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$207 ﹤0.01%
4
– –
ARAY icon
567
Accuray
ARAY
$27.5M
$180 ﹤0.01%
100
– –
LUMN icon
568
Lumen
LUMN
$6.43B
$178 ﹤0.01%
+25
New +$107
USIG icon
569
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$178 ﹤0.01%
3
– –
IBRX icon
570
ImmunityBio
IBRX
$7.15B
$149 ﹤0.01%
40
– –
VOD icon
571
Vodafone
VOD
$37.1B
$140 ﹤0.01%
+14
New +$134
WW
572
DELISTED
WW International
WW
$140 ﹤0.01%
160
– –
KD icon
573
Kyndryl
KD
$3.09B
$138 ﹤0.01%
6
– –
APTO
574
DELISTED
Aptose Biosciences, Inc.
APTO
$123 ﹤0.01%
10
– –
AVGR
575
DELISTED
Avinger, Inc. Common Stock
AVGR
$121 ﹤0.01%
127
– –
21 22
23
24 25

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return

HighMark Wealth Management's Q3 2024 Portfolio in Review

As of Q3 2024, HighMark Wealth Management held 624 positions worth $183M, up 9.9% from $166M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

HighMark Wealth Management's Q3 2024 filing shows 37 new, 151 increased, 119 reduced and 30 closed positions. Its largest new stake was Evolent Health: 20,475 shares worth $579K. The largest sale was Aurinia Pharmaceuticals, an estimated $431K.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q3 2024 buy was Evolent Health: 20,475 shares worth $579K.
  • HighMark Wealth Management added most to Paragon 28, Inc. in Q3 2024, an estimated $3.19M increase.
  • HighMark Wealth Management's biggest Q3 2024 reduction was Aurinia Pharmaceuticals, cutting an estimated $431K.
  • HighMark Wealth Management fully exited ProShares Short S&P500 in Q3 2024, selling an estimated $40.2K.
  • HighMark Wealth Management's ten largest holdings make up 70% of its $183M portfolio in Q3 2024.
  • HighMark Wealth Management opened 37 new positions and closed 30 in Q3 2024.
  • HighMark Wealth Management's portfolio value rose 9.9% quarter-over-quarter to $183M.

Based on HighMark Wealth Management's 13F filing for Q3 2024, filed 17 Oct 2024.